FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly ophthalmology, namely eye drops for dry eye syndrome with the formulation containing a lachrymal substitute and a corticosteroid: dexamethasone or betamethasone. The eye drops contain the following ingredients (wt %): dexamethasone phosphate or betamethasone phosphate - 0.000001-1.0; hydroxypropyl cellulose - 0.01-5.0; histidine hydrochloride monohydrate 0.01-0.025; boric acid 0.01-0.08; sodium tetraborate 0.0001-0.02; macrogol 400 - 0.001-0.1; disoudium edetate 0.001-0.05; potassium chloride - 0.001-0.008; sodium chloride 0.001-0.016 and the rest - purified water.
EFFECT: invention provides avoiding external eye irritation.
6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
| EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
| EYE DROPS | 2012 |
|
RU2504372C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
| OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
| ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
| GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
